U.S. Markets open in 3 hrs 49 mins

What’s the Potential Market for Accelerate Diagnostics’ Products?

Kenneth Smith
What’s the Potential Market for Accelerate Diagnostics’ Products?

How Is Accelerate Diagnostics Positioned at the Start of 2018? Accelerate Diagnostics’ (AXDX) Pheno System utilizes genotypic and phenotypic technology to identify infectious pathogens and perform antibiotic susceptibility tests (or AST), which determine if live bacterial or fungal cells are resistant or susceptible to a particular antimicrobial agent. The kit includes 140 assays for identification and susceptibility testing.